Brief Communication: Factors associated with willingness to use long-acting injectable Cabotegravir for HIV pre-exposure prophylaxis (PrEP) among female undergraduate students at a Ugandan university

Bridget Atuhaire; Laban Muteebwa; Racheal Nabunya; Richard Muhindo; Tom Denis Ngabirano; Charles Peter Osingada; Patience A. Muwanguzi

doi:10.1186/s12981-024-00686-5

Brief Communication: Factors associated with willingness to use long-acting injectable Cabotegravir for HIV pre-exposure prophylaxis (PrEP) among female undergraduate students at a Ugandan university

Bridget Atuhaire, Laban Muteebwa, Racheal Nabunya, Richard Muhindo, Tom Denis Ngabirano, Charles Peter Osingada, Patience A. Muwanguzi

Academics (Nursing)

Research output: Contribution to journal › Article › peer-review

Abstract

Background: We assessed the willingness of female students at a Ugandan public university to use long-acting Cabotegravir (CAB-LA) for HIV prevention, given their high prevalence of HIV risk behaviours. Methods: Using an online questionnaire, this cross-sectional study surveyed 346 female undergraduate students aged 18–25. Factors influencing their willingness were analysed with modified Poisson regression and robust standard errors. Results: More than half, 56.7% (95% CI: 51.4 to 61.8), were willing to use CAB-LA. Willingness was significantly associated with being sexually active in the past 3 months, using alcohol in the past 6 months, or being in the 4th year of study compared to the 1st year. Conclusion: Educational initiatives on innovative HIV prevention strategies, such as CAB-LA, should be introduced early in university students’ studies to increase awareness and acceptance.

Original language	English (US)
Article number	95
Journal	AIDS Research and Therapy
Volume	21
Issue number	1
DOIs	https://doi.org/10.1186/s12981-024-00686-5
State	Published - Dec 2024

Bibliographical note

Publisher Copyright:
© The Author(s) 2024.

Keywords

Long-acting cabotegravir
Pre-exposure prophylaxis
Students
Willingness

PubMed: MeSH publication types

Journal Article

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1186/s12981-024-00686-5

Find It

Find It at U of M Libraries

Cite this

Atuhaire, B., Muteebwa, L., Nabunya, R., Muhindo, R., Ngabirano, T. D., Osingada, C. P., & Muwanguzi, P. A. (2024). Brief Communication: Factors associated with willingness to use long-acting injectable Cabotegravir for HIV pre-exposure prophylaxis (PrEP) among female undergraduate students at a Ugandan university. AIDS Research and Therapy, 21(1), Article 95. https://doi.org/10.1186/s12981-024-00686-5

Brief Communication: Factors associated with willingness to use long-acting injectable Cabotegravir for HIV pre-exposure prophylaxis (PrEP) among female undergraduate students at a Ugandan university. / Atuhaire, Bridget; Muteebwa, Laban; Nabunya, Racheal et al.
In: AIDS Research and Therapy, Vol. 21, No. 1, 95, 12.2024.

Research output: Contribution to journal › Article › peer-review

Atuhaire, B, Muteebwa, L, Nabunya, R, Muhindo, R, Ngabirano, TD, Osingada, CP & Muwanguzi, PA 2024, 'Brief Communication: Factors associated with willingness to use long-acting injectable Cabotegravir for HIV pre-exposure prophylaxis (PrEP) among female undergraduate students at a Ugandan university', AIDS Research and Therapy, vol. 21, no. 1, 95. https://doi.org/10.1186/s12981-024-00686-5

@article{c9f47925fb9b44a8a0db0d229e5eacac,

title = "Brief Communication: Factors associated with willingness to use long-acting injectable Cabotegravir for HIV pre-exposure prophylaxis (PrEP) among female undergraduate students at a Ugandan university",

abstract = "Background: We assessed the willingness of female students at a Ugandan public university to use long-acting Cabotegravir (CAB-LA) for HIV prevention, given their high prevalence of HIV risk behaviours. Methods: Using an online questionnaire, this cross-sectional study surveyed 346 female undergraduate students aged 18–25. Factors influencing their willingness were analysed with modified Poisson regression and robust standard errors. Results: More than half, 56.7% (95% CI: 51.4 to 61.8), were willing to use CAB-LA. Willingness was significantly associated with being sexually active in the past 3 months, using alcohol in the past 6 months, or being in the 4th year of study compared to the 1st year. Conclusion: Educational initiatives on innovative HIV prevention strategies, such as CAB-LA, should be introduced early in university students{\textquoteright} studies to increase awareness and acceptance.",

keywords = "Long-acting cabotegravir, Pre-exposure prophylaxis, Students, Willingness",

author = "Bridget Atuhaire and Laban Muteebwa and Racheal Nabunya and Richard Muhindo and Ngabirano, {Tom Denis} and Osingada, {Charles Peter} and Muwanguzi, {Patience A.}",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2024.",

year = "2024",

month = dec,

doi = "10.1186/s12981-024-00686-5",

language = "English (US)",

volume = "21",

journal = "AIDS Research and Therapy",

issn = "1742-6405",

publisher = "BioMed Central",

number = "1",

}

TY - JOUR

T1 - Brief Communication: Factors associated with willingness to use long-acting injectable Cabotegravir for HIV pre-exposure prophylaxis (PrEP) among female undergraduate students at a Ugandan university

AU - Atuhaire, Bridget

AU - Muteebwa, Laban

AU - Nabunya, Racheal

AU - Muhindo, Richard

AU - Ngabirano, Tom Denis

AU - Osingada, Charles Peter

AU - Muwanguzi, Patience A.

PY - 2024/12

Y1 - 2024/12

N2 - Background: We assessed the willingness of female students at a Ugandan public university to use long-acting Cabotegravir (CAB-LA) for HIV prevention, given their high prevalence of HIV risk behaviours. Methods: Using an online questionnaire, this cross-sectional study surveyed 346 female undergraduate students aged 18–25. Factors influencing their willingness were analysed with modified Poisson regression and robust standard errors. Results: More than half, 56.7% (95% CI: 51.4 to 61.8), were willing to use CAB-LA. Willingness was significantly associated with being sexually active in the past 3 months, using alcohol in the past 6 months, or being in the 4th year of study compared to the 1st year. Conclusion: Educational initiatives on innovative HIV prevention strategies, such as CAB-LA, should be introduced early in university students’ studies to increase awareness and acceptance.

AB - Background: We assessed the willingness of female students at a Ugandan public university to use long-acting Cabotegravir (CAB-LA) for HIV prevention, given their high prevalence of HIV risk behaviours. Methods: Using an online questionnaire, this cross-sectional study surveyed 346 female undergraduate students aged 18–25. Factors influencing their willingness were analysed with modified Poisson regression and robust standard errors. Results: More than half, 56.7% (95% CI: 51.4 to 61.8), were willing to use CAB-LA. Willingness was significantly associated with being sexually active in the past 3 months, using alcohol in the past 6 months, or being in the 4th year of study compared to the 1st year. Conclusion: Educational initiatives on innovative HIV prevention strategies, such as CAB-LA, should be introduced early in university students’ studies to increase awareness and acceptance.

KW - Long-acting cabotegravir

KW - Pre-exposure prophylaxis

KW - Students

KW - Willingness

UR - http://www.scopus.com/inward/record.url?scp=85212782296&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85212782296&partnerID=8YFLogxK

U2 - 10.1186/s12981-024-00686-5

DO - 10.1186/s12981-024-00686-5

M3 - Article

C2 - 39707475

AN - SCOPUS:85212782296

SN - 1742-6405

VL - 21

JO - AIDS Research and Therapy

JF - AIDS Research and Therapy

IS - 1

M1 - 95

ER -